← Patents

2022 · pending · MX2025006351A

Treatment of MTRES1 Related Diseases and Disorders

Gregory McInnes

Compositions comprising oligonucleotides (siRNA or ASO) that target MTRES1 for treating conditions associated with MTRES1 gene mutations.

RNA Therapeutics